Back
PubMed

Characterizing clinical heterogeneity by whole-genome sequencing of 591 patients with Hemoglobin H disease

Liu Y, Zhang X, Chen J, et al. — Blood Adv 2026 · November 2026
Relevance score
6/10
Disease / domain
Hemoglobin H disease (α-thalassemia)
Source
PubMed
PMID 43008312

Variant / mechanism

Genetic modifiers: α-globin cluster variants and the HBS1L-MYB (HMIP) locus associated with Hb Bart's levels

Summary

This whole-genome study, the largest to date in Hemoglobin H disease, includes 591 well-characterized patients and 1,246 ancestry-matched controls from Southern China. Case-control analysis identified two independent variants at the α-globin cluster (rs199594877 and rs34583256), more frequent in patients, with rs199594877 enriched in carriers of Hb Constant Spring. Case-only analysis of 50 quantitative clinical traits identified six loci associated with hematological and iron metabolism phenotypes. At the HBS1L-MYB (HMIP) locus, rs11759553 was associated with increased Hb Bart's (γ4) levels (P = 3.66 × 10⁻¹⁴), in contrast, according to the authors, with the beneficial effect of this locus in β-hemoglobinopathies.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A genome-phenome resource that helps explain why two patients with the same α-globin genotype differ in severity, but with no immediate consequence for counselling or management. The abstract mentions no replication cohort, and the opposite effect of the HMIP locus compared with β-hemoglobinopathies needs functional validation before any prognostic use.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 1/3Evidence 2/3Novelty 1/2Sample 1/1Publication 1/1

Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 6/10

Keywords

WGSα-thalassemiaHemoglobin H diseasemodifier genesGWAS
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime